(thirdQuint)Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.

5 mg Tablets Under Fasting Conditions.

 This study was a single dose, randomized, two period, two treatment, two sequence crossover study design was used to evaluate the relative bioavailability of Fosinopril sodium and hydrochlorothiazide tablet products when dose (1 x 20-12.

5 mg) under fasting conditions.

 The two periods of the study were separated by a washout period of at least a week.

 A total of 36 healthy adult subjects were enrolled in the study.

 Of all the subjects 34 subjects (21 males and 13 females) completed the study.

.

 Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.

5 mg Tablets Under Fasting Conditions@highlight

The objective of this study was to compare the relative bioavailability of Fosinopril sodium and hydrochlorothiazide 20-12.

5 mg tablets by Ranbaxy Laboratories Limited with that of Monopril (R).

-HCT 20-12.

5 mg tablets by Bristol-Meyers Squibb following a single oral dose (1 x 20-12.

5 mg tablet) in healthy adult subjects under fasting conditions